MaxCyte Inc
MXCT1.470USD
-0.200-11.98%
收盤 11/06, 16:00（美東）報價延遲15分鐘
156.69M總市值
虧損本益比TTM
關於 MaxCyte Inc 公司
MaxCyte, Inc. 是一家專注於細胞工程的公司，提供解決方案以促進細胞療法的發現、開發和商業化。該公司利用其細胞工程技術平臺來支持從事細胞療法的生物技術和製藥公司客戶的計劃。其 ExPERT 平臺基於其流式電穿孔技術，旨在支持不斷擴大的細胞療法市場，並可用於整個細胞療法領域，從發現和開發到下一代細胞藥物的商業化。ExPERT 系列產品包括四種儀器，即 ATx、STx、GTx 和 VLx；一系列專有相關處理組件或一次性用品；以及軟件協議，所有這些都由全球知識產權組合支持。該公司還通過 ONE-seq 和 GUIDE-seq 平臺爲基因編輯提供全面的脫靶風險評估解決方案。
MaxCyte Inc簡介
公司代碼MXCT
公司名稱MaxCyte Inc
上市日期Mar 29, 2016
CEOMr. Maher Masoud, J.D.
員工數量114
證券類型Ordinary Share
年結日Mar 29
公司地址9713 Key West Avenue,
城市ROCKVILLE
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編20850
電話13015175556
網址https://www.maxcyte.com/
公司代碼MXCT
上市日期Mar 29, 2016
CEOMr. Maher Masoud, J.D.
MaxCyte Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Stanley C. (Stan) Erck
Mr. Stanley C. (Stan) Erck
Non-Executive Independent Director
Non-Executive Independent Director
398.33K
+33.52%
Dr. Richard H. Douglas, Ph.D.
Dr. Richard H. Douglas, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
230.58K
+53.13%
Mr. Maher Masoud, J.D.
Mr. Maher Masoud, J.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
175.00K
+75.00%
Mr. John Joseph Johnston
Mr. John Joseph Johnston
Non-Executive Independent Director
Non-Executive Independent Director
171.16K
+20.58%
Dr. Yasir B. Al-Wakeel
Dr. Yasir B. Al-Wakeel
Non-Executive Independent Director
Non-Executive Independent Director
50.58K
+136.71%
Mr. Douglas J. (Doug) Swirsky
Mr. Douglas J. (Doug) Swirsky
Chief Financial Officer
Chief Financial Officer
50.00K
--
Ms. Rekha Hemrajani
Ms. Rekha Hemrajani
Non-Executive Independent Director
Non-Executive Independent Director
39.89K
+86.70%
Ms. Cynthia L. Collins
Ms. Cynthia L. Collins
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William W. (Will) Brooke, J.D.
Mr. William W. (Will) Brooke, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Patrick J. Balthrop
Mr. Patrick J. Balthrop
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Stanley C. (Stan) Erck
Mr. Stanley C. (Stan) Erck
Non-Executive Independent Director
Non-Executive Independent Director
398.33K
+33.52%
Dr. Richard H. Douglas, Ph.D.
Dr. Richard H. Douglas, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
230.58K
+53.13%
Mr. Maher Masoud, J.D.
Mr. Maher Masoud, J.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
175.00K
+75.00%
Mr. John Joseph Johnston
Mr. John Joseph Johnston
Non-Executive Independent Director
Non-Executive Independent Director
171.16K
+20.58%
Dr. Yasir B. Al-Wakeel
Dr. Yasir B. Al-Wakeel
Non-Executive Independent Director
Non-Executive Independent Director
50.58K
+136.71%
Mr. Douglas J. (Doug) Swirsky
Mr. Douglas J. (Doug) Swirsky
Chief Financial Officer
Chief Financial Officer
50.00K
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
業務USD
名稱
營收
佔比
Product sales
5.27M
61.94%
Licenses
2.93M
34.42%
other
310.00K
3.64%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Product sales
5.27M
61.94%
Licenses
2.93M
34.42%
other
310.00K
3.64%
股東統計
更新時間: 8月17日 週日
更新時間: 8月17日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Cadian Capital Management LP
8.36%
BlackRock Institutional Trust Company, N.A.
7.70%
Mirabella Financial Services LLP
7.69%
The Vanguard Group, Inc.
5.25%
River Global Investors LLP
5.16%
其他
65.84%
持股股東
持股股東
佔比
Cadian Capital Management LP
8.36%
BlackRock Institutional Trust Company, N.A.
7.70%
Mirabella Financial Services LLP
7.69%
The Vanguard Group, Inc.
5.25%
River Global Investors LLP
5.16%
其他
65.84%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
26.22%
Investment Advisor
23.95%
Hedge Fund
16.61%
Research Firm
4.83%
Private Equity
4.73%
Individual Investor
1.74%
Bank and Trust
0.67%
Pension Fund
0.17%
Venture Capital
0.16%
其他
20.91%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
286
81.96M
76.90%
-18.01M
2025Q2
296
78.80M
73.92%
-18.62M
2025Q1
308
82.56M
77.59%
-14.89M
2024Q4
308
80.42M
75.91%
-14.30M
2024Q3
300
80.65M
76.72%
-18.62M
2024Q2
297
80.25M
76.66%
-17.97M
2024Q1
302
79.09M
75.86%
-22.52M
2023Q4
303
79.97M
77.01%
-14.24M
2023Q3
292
77.05M
74.47%
-17.27M
2023Q2
284
79.82M
77.43%
-11.81M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Cadian Capital Management LP
8.91M
8.36%
-1.11M
-11.10%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
8.21M
7.7%
+793.69K
+10.70%
Jun 30, 2025
Mirabella Financial Services LLP
6.60M
6.19%
+2.90M
+78.38%
Jun 30, 2025
The Vanguard Group, Inc.
5.60M
5.25%
+36.02K
+0.65%
Jun 30, 2025
River Global Investors LLP
3.25M
3.05%
+1.19M
+57.73%
Dec 31, 2024
Vitruvian Partners LLP
5.04M
4.73%
--
--
Jun 30, 2025
Morgan Stanley & Co. LLC
4.23M
3.97%
+795.36K
+23.12%
Jun 30, 2025
Mudita Advisors LLP
3.37M
3.16%
+42.25K
+1.27%
Jun 30, 2025
Morgan Stanley Investment Management Inc. (US)
2.69M
2.52%
-859.73K
-24.21%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.48M
2.33%
-100.52K
-3.89%
Jun 30, 2025
查看更多
持股ETF
更新時間: 19 小時前
更新時間: 19 小時前
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.55%
iShares Micro-Cap ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.02%
Avantis US Small Cap Equity ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
iShares Biotechnology ETF
0.02%
iShares Russell 2000 Value ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.55%
iShares Micro-Cap ETF
佔比0.03%
Invesco Nasdaq Biotechnology ETF
佔比0.02%
Avantis US Small Cap Equity ETF
佔比0.02%
ProShares Ultra Nasdaq Biotechnology
佔比0.02%
iShares Biotechnology ETF
佔比0.02%
iShares Russell 2000 Value ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
